Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2012

View Archived Issues

Kythera launches pivotal ATX-101 program

NINA device-coupled RT-LAMP assay allows point-of-care HIV-1 detection

Takeda patents novel antipsychotic drugs

New therapeutics for vascular disease designed in India

Novel antibacterials developed in Israel

ImmunoGen reports new HER3-binding immunotherapies

Bristol-Myers Squibb divulges new products to treat HIV infection

Boston Scientific announces new product launch in Japan

Mitsubishi Tanabe and Daiichi Sankyo enter strategic alliance

FDA accepts NDA resubmitted by Eisai

Phase II AMG-853 trial does not meet primary endpoint

Pre-IND meeting scheduled for influenza drug

Concert Pharmaceuticals enters new collaboation

Canadian study reveals new potential tool for prostate cancer diagnosis

Savient launches named-patient program for gout therapy

Anticancer drugs are possible treatments for lethal Ebola virus infections

Acadia Pharmaceuticals and Allergan extend drug discovery collaboration

Zalicus completes trial of reformulated N-type calcium channel blocker

BioLineRx clear to begin study of BL-7040

FDA issues complete response letter for ezetimibe/atorvastatin tablets

Anthera Pharmaceuticals to continue blisibimod study as planned

MorphoSys completes enrollment in rheumatoid arthritis study

VistaGen partners with Duke University

International phase III trial of MLN-8237 begins

Mayo Clinic receives NIH grant to research use of new peptide to treat heart attacks

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...